%0 Journal Article %J PloS one %D 2015 %T Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade. %A Do, Albert %A Mittal, Yash %A Liapakis, AnnMarie %A Cohen, Elizabeth %A Chau, Hong %A Bertuccio, Claudia %A Sapir, Dana %A Wright, Jessica %A Eggers, Carol %A Drozd, Kristine %A Ciarleglio, Maria %A Deng, Yanhong %A Lim, Joseph K %N 8 %P e0135645 %R 10.1371/journal.pone.0135645 %V 10 %X New treatments for hepatitis C (HCV) infection hold great promise for cure, but numerous challenges to diagnosing, establishing care, and receiving therapy exist. There are limited data on insurance authorization for these medications. %8 2015